Position in BRNS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,957,291
-$680,853 QoQ
Shares Held
5,197,349
0.0% QoQ
Ownership
12.7%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BRNS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026M&G PLC holds $145,893,196 across 13 Biotechnology names. BRNS ranks #10 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
138,163 | $41,030,266 | |
| 2 | INSM |
INSMED Inc
|
98,221 | $16,061,097 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
91,339 | $15,438,117 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
226,541 | $12,797,301 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
37,656 | $12,459,240 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
138,567 | $12,051,171 | |
| 7 | TARS |
Tarsus Pharmaceuticals, Inc.
|
166,364 | $11,670,434 | |
| 8 | ARQT |
Arcutis Biotherapeutics, Inc.
|
469,082 | $11,051,571 |
All Filings in BRNS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,957,291 | 5,197,349 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,638,144 | 5,197,349 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $6,496,686 | 5,197,349 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $4,833,534 | 5,197,349 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $5,057,020 | 5,197,349 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $6,278,397 | 5,197,349 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $6,184,845 | 5,197,349 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $7,276,288 | 5,197,349 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $12,369,690 | 5,197,349 | Shares | Sole | 2024-05-10 | |
| No filing history on record for this holder in this stock. | ||||||